首页> 美国卫生研究院文献>Nature Communications >Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism
【2h】

Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism

机译:哺乳动物APE1控制miRNA加工其相互作用基因组与癌症RNA代谢相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mammalian apurinic/apyrimidinic endonuclease 1 is a DNA repair enzyme involved in genome stability and expression of genes involved in oxidative stress responses, tumor progression and chemoresistance. However, the molecular mechanisms underlying the role of apurinic/apyrimidinic endonuclease 1 in these processes are still unclear. Recent findings point to a novel role of apurinic/apyrimidinic endonuclease 1 in RNA metabolism. Through the characterization of the interactomes of apurinic/apyrimidinic endonuclease 1 with RNA and other proteins, we demonstrate here a role for apurinic/apyrimidinic endonuclease 1 in pri-miRNA processing and stability via association with the DROSHA-processing complex during genotoxic stress. We also show that endonuclease activity of apurinic/apyrimidinic endonuclease 1 is required for the processing of miR-221/222 in regulating expression of the tumor suppressor PTEN. Analysis of a cohort of different cancers supports the relevance of our findings for tumor biology. We also show that apurinic/apyrimidinic endonuclease 1 participates in RNA-interactomes and protein-interactomes involved in cancer development, thus indicating an unsuspected post-transcriptional effect on cancer genes.
机译:哺乳动物嘌呤/嘧啶内切核酸酶1是一种DNA修复酶,参与基因组稳定性和涉及氧化应激反应,肿瘤进展和化学抗性的基因表达。但是,在这些过程中,嘌呤/嘧啶核酸内切酶1的潜在分子机制尚不清楚。最近的发现指出了嘌呤/嘧啶内切核酸酶1在RNA代谢中的新作用。通过对嘌呤/嘧啶核糖核酸内切酶1与RNA和其他蛋白质的相互作用组进行表征,我们在这里证明了嘌呤/嘧啶核糖核酸内切酶1在pri-miRNA加工中的作用以及通过与DROSHA加工复合物在遗传毒性胁迫中的缔合而稳定。我们还表明,嘌呤/嘧啶核糖核酸内切酶1的核酸内切酶活性是miR-221 / 222在调节肿瘤抑制因子PTEN表达中的处理所必需的。对不同癌症队列的分析支持了我们的发现与肿瘤生物学的相关性。我们还显示,嘌呤/ apyrimidinic核酸内切酶1参与参与癌症发展的RNA-interactomes和蛋白质-interactomes,从而表明对癌症基因的意想不到的转录后作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号